Treatments

Health Effects of Wildfires: Recent Research and What Clinicians Need to Know

By

Tori Rodriguez, MA, LPC, AHC

Publish Date September 30, 2022

In addition to worsening asthma, other respiratory disorders, and heart conditions, exposure to wildfire smoke can also compromise immunity in healthy individuals.

How the COVID-19 Pandemic Altered the Course of Antimicrobial Resistance

By

Anne Meneghetti, MD

Publish Date September 27, 2022

Anne Meneghetti, MD, discusses the effects of the COVID-19 pandemic on inappropriate antibiotic use in both the inpatient and outpatient setting.

ACCP Updates Guideline for Perioperative Management of Antithrombotic Therapy

By

Colby Stong

Publish Date September 23, 2022

New topics in the ACCP guideline include the perioperative management of patients receiving direct oral anticoagulants and P2Y12 inhibitor antiplatelet drugs.

Cannabidiol Gets Orphan Drug Status for Preventing Ischemia-Reperfusion Injury

By

Steve Duffy

The designation was granted to Revive Therapeutics, a company that specializes in cannabis-based pharmaceuticals.

Chest Tube Placement vs Needle Aspiration for Spontaneous Pneumothorax

By

Bryant Moeller

Both chest tube placement and needle aspiration were considered acceptable treatments for primary spontaneous pneumothorax.

NDA for Novel Amikacin Inhalation Submitted for Rare Lung Infection

By

Steve Duffy

ALIS has previously been designated orphan drug status, breakthrough therapy status and a Qualified Infectious Disease Product.

No Benefit From Prophylactic Antimicrobials in Aspiration Pneumonitis

By

Bradley van Paridon

Use of prophylactic antimicrobial therapy was not associated with a reduction in mortality or transfer to critical care compared with patients managed with supportive care only.

Drainage Duration, Length of Hospital Stay With Different Pneumothorax Treatments

By

Anna Kitabjian

Treatment with a small pigtail catheter may shorten the drainage duration and length of hospital stay in patients with spontaneous pneumothorax.

FDA Approves New CFTR Modulator Therapy for Cystic Fibrosis

By

Britt Gambino

A new cystic fibrosis transmembrane conductance regulator modulator treatment has been approved by the FDA for use in patients aged 12 years and older.

Enteral vs Parenteral Nutrition in Critical Care Requiring Mechanical Ventilation

By

Laurel Ranger

Enteral nutritional support was not clinically superior to parenteral nutritional support in critically ill patients receiving mechanical ventilation.

Examining Compression-to-Ventilation Ratios for Optimal Neurologic, Survival Outcomes

By

Anna Kitabjian

Adults with cardiac arrest have better outcomes with continuous compressions with asynchronous ventilations or compression-to-ventilation ratios of 30:2.